Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Acro Biomedical (ACBM) Change in Account Payables (2016 - 2021)

Acro Biomedical has reported Change in Account Payables over the past 4 years, most recently at $10125.0 for Q4 2021.

  • Quarterly results put Change in Account Payables at $10125.0 for Q4 2021, down 48.5% from a year ago — trailing twelve months through Dec 2021 was $37787.0 (up 45.88% YoY), and the annual figure for FY2022 was $50374.0, up 3343.2%.
  • Change in Account Payables for Q4 2021 was $10125.0 at Acro Biomedical, up from $4000.0 in the prior quarter.
  • Over the last five years, Change in Account Payables for ACBM hit a ceiling of $19662.0 in Q4 2020 and a floor of -$5030.0 in Q1 2017.
  • Median Change in Account Payables over the past 3 years was $4000.0 (2020), compared with a mean of $6551.4.
  • Peak annual rise in Change in Account Payables hit 0.0% in 2021, while the deepest fall reached 48.5% in 2021.
  • Acro Biomedical's Change in Account Payables stood at -$5030.0 in 2017, then surged by 490.89% to $19662.0 in 2020, then tumbled by 48.5% to $10125.0 in 2021.
  • The last three reported values for Change in Account Payables were $10125.0 (Q4 2021), $4000.0 (Q3 2021), and $19662.0 (Q4 2020) per Business Quant data.